Direct oral anticoagulant (DOAC) reversal: Andexxa versus 4 factor prothrombin concentrates
- PMID: 31606337
- DOI: 10.1016/j.transci.2019.09.002
Direct oral anticoagulant (DOAC) reversal: Andexxa versus 4 factor prothrombin concentrates
Keywords: Andexanet; Anticoagulant reversal; Bleeding; Complication of anticoagulation.
Conflict of interest statement
Declaration of Competing Interest The authors have no relevant conflicts of interest to disclose
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical